REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 18th, 2017 • Premier Biomedical Inc • Biological products, (no disgnostic substances)
This Agreement is entered into pursuant to the Securities Purchase Agreement, dated as of the date hereof, by and between the Company and each Purchaser (the “Purchase Agreement”).
SERIES A COMMON STOCK PURCHASE WARRANT PREMIER BIOMEDICAL, INC.Security Agreement • May 18th, 2017 • Premier Biomedical Inc • Biological products, (no disgnostic substances)
THIS SERIES A COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [•] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the three (3) year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Premier Biomedical, Inc., a Nevada corporation (the “Company”), up to [•] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 18th, 2017 • Premier Biomedical Inc • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of March 30, 2017, between Premier Biomedical, Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
